The antigen-dependent activation and inactivation of CD4 T cells
CD4 T 细胞的抗原依赖性激活和失活
基本信息
- 批准号:RGPIN-2018-04117
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Immune systems respond to fight foreign invaders and yet do not respond to "self" cells or molecules. This attribute of the immune system is referred to as self-nonself discrimination. There are two recognized mechanisms by which the ability to respond against self antigens is ablated. Firstly, lymphocytes with receptors that bind to self-antigens are ablated on interacting with the antigen when first generated in the organs supporting lymphocyte development. Some "peripheral" self-antigens are insufficiently present in such organs to ablate their corresponding lymphocytes. Thus the pool of mature lymphocytes, that circulates via the blood and traffics through the spleen and lymph nodes, contains some lymphocytes specific for these peripheral self antigens. The inappropriate activation of these lymphocytes can result in autoimmunity. Mature lymphocytes can be inactivated (the second mechanism of ablation) or activated by antigen, the latter process resulting in the cells that mediate immune responses, for example antibody producing cells. There are three classes of lymphocytes. The activation of B cells gives rise to cells that produce antibody; of "CD8 T lymphocytes" to cytotoxic T lymphocytes (CTL) that kill virally-infected or cancer cells; and of CD4 T lymphocytes to T helper (Th) cells that allow antigen to facilitate or help in the activation of B and CD8 cells. We proposed in 1970 that a single lymphocyte interacting with antigen would be inactivated, whereas the activation of a target lymphocyte required its antigen-mediated interaction with antigen-specific Th cells, providing a mechanism by which lymphocytes specific for peripheral self-antigens could be ablated and lymphocytes specific for foreign antigens activated. This idea was supported by the subsequent findings that Th cells are required for antigen to activate B and CD8 T cells, and their inactivation by antigen in the absence of Th cells. The studies proposed will test a detailed hypothesis for how antigen interacts differently with CD4 T cells to activate or inactivate them. This hypothesis incorporates the idea that a single target CD4 T will be inactivated by antigen, whereas its activation requires help from another CD4 T cell, i.e. requires CD4 T cell cooperation. Our hypothesis is contrary to the ideas most immunologists currently hold. We argue it is both better supported by observation and is physiologically more plausible. Moreover, all agree that the different circumstances leading to the antigen-dependent activation or inactivation of CD4 T cells is a most critical question, as it appears that such activation is required to initiate almost all adaptive immune responses. Thus an understanding of these circumstances is required to envisage how autoimmunity to peripheral self antigens can occur and how the strength of immune responses can be facilitated by increasing the effective activation of CD4 T cells.
免疫系统会对外来入侵者做出反应,但不会对“自我”细胞或分子做出反应。免疫系统的这种属性被称为自我-非自我辨别。有两种公认的机制可以消除对自身抗原的反应能力。首先,具有与自身抗原结合的受体的淋巴细胞在支持淋巴细胞发育的器官中首次产生时在与抗原相互作用时被消融。一些“外周”自身抗原在这些器官中不足以消融它们相应的淋巴细胞。因此,通过血液循环并通过脾脏和淋巴结运输的成熟淋巴细胞库包含一些对这些外周自身抗原特异性的淋巴细胞。这些淋巴细胞的不适当活化可导致自身免疫。成熟的淋巴细胞可以被抗原灭活(第二种消融机制)或激活,后一种过程产生介导免疫应答的细胞,例如抗体产生细胞。 淋巴细胞有三类。B细胞的活化产生产生抗体的细胞;“CD 8 T淋巴细胞”产生杀死病毒感染细胞或癌细胞的细胞毒性T淋巴细胞(CTL);以及CD 4 T淋巴细胞产生T辅助(Th)细胞,其允许抗原促进或帮助B和CD 8细胞的活化。我们在1970年提出,与抗原相互作用的单个淋巴细胞将被灭活,而靶淋巴细胞的激活需要其与抗原特异性Th细胞的抗原介导的相互作用,提供了一种机制,通过这种机制,对外周自身抗原特异性的淋巴细胞可以被消融,对外来抗原特异性的淋巴细胞被激活。随后的发现支持了这一想法,即Th细胞是抗原激活B和CD 8 T细胞所必需的,并且在Th细胞不存在的情况下抗原使它们失活。这些研究将测试一个详细的假设,即抗原如何与CD 4 T细胞发生不同的相互作用,以激活或抑制它们。该假设结合了单个靶CD 4 T将被抗原灭活的想法,而其活化需要另一个CD 4 T细胞的帮助,即需要CD 4 T细胞合作。我们的假设与大多数免疫学家目前持有的观点相反。我们认为,这是更好地支持观察和生理上更合理。此外,所有人都同意,导致CD 4 T细胞抗原依赖性活化或失活的不同情况是一个最关键的问题,因为似乎这种活化是启动几乎所有适应性免疫应答所必需的。因此,需要了解这些情况,以设想如何发生对外周自身抗原的自身免疫,以及如何通过增加CD 4 T细胞的有效活化来促进免疫应答的强度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bretscher, Peter其他文献
Synthesis of Epoxyisoprostanes: Effects in Reducing Secretion of Pro-inflammatory Cytokines IL-6 and IL-12
- DOI:
10.1002/anie.201300739 - 发表时间:
2013-01-01 - 期刊:
- 影响因子:16.6
- 作者:
Egger, Julian;Bretscher, Peter;Carreira, Erick M. - 通讯作者:
Carreira, Erick M.
Discovery of a Highly Potent Anti-inflammatory Epoxyisoprostane-Derived Lactone
- DOI:
10.1021/ja509892u - 发表时间:
2014-12-17 - 期刊:
- 影响因子:15
- 作者:
Egger, Julian;Bretscher, Peter;Carreira, Erick M. - 通讯作者:
Carreira, Erick M.
Macroimmunology and immunotherapy of cancer
- DOI:
10.2217/imt.09.6 - 发表时间:
2009-05-01 - 期刊:
- 影响因子:2.8
- 作者:
Hamilton, Duane;Ismail, Nahed;Bretscher, Peter - 通讯作者:
Bretscher, Peter
Bretscher, Peter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bretscher, Peter', 18)}}的其他基金
The antigen-dependent activation and inactivation of CD4 T cells
CD4 T 细胞的抗原依赖性激活和失活
- 批准号:
RGPIN-2018-04117 - 财政年份:2021
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
The antigen-dependent activation and inactivation of CD4 T cells
CD4 T 细胞的抗原依赖性激活和失活
- 批准号:
RGPIN-2018-04117 - 财政年份:2020
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
The antigen-dependent activation and inactivation of CD4 T cells
CD4 T 细胞的抗原依赖性激活和失活
- 批准号:
RGPIN-2018-04117 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
The antigen-dependent activation and inactivation of CD4 T cells
CD4 T 细胞的抗原依赖性激活和失活
- 批准号:
RGPIN-2018-04117 - 财政年份:2018
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Regulation of the function of CD4 T cells
CD4 T 细胞功能的调节
- 批准号:
327335-2013 - 财政年份:2017
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Regulation of the function of CD4 T cells
CD4 T 细胞功能的调节
- 批准号:
327335-2013 - 财政年份:2016
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Regulation of the function of CD4 T cells
CD4 T 细胞功能的调节
- 批准号:
327335-2013 - 财政年份:2015
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Regulation of the function of CD4 T cells
CD4 T 细胞功能的调节
- 批准号:
327335-2013 - 财政年份:2014
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Regulation of the function of CD4 T cells
CD4 T 细胞功能的调节
- 批准号:
327335-2013 - 财政年份:2013
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
Cellular and molecular interactions determining whether antigen signals the activation or inactivation of CD4 T cells
细胞和分子相互作用决定抗原是否发出 CD4 T 细胞激活或失活信号
- 批准号:
327335-2008 - 财政年份:2012
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
- 批准号:82371585
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
- 批准号:82371660
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
当归芍药散基于双向调控Ras/cAMP-dependent PKA自噬通路的“酸甘化阴、辛甘化阳”的药性基础
- 批准号:81973497
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
CDK5调节羊驼黑色素生成的作用研究
- 批准号:31201868
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
蒺藜苜蓿细胞周期蛋白依赖性激酶(cyclin-dependent kinase)对根瘤发育的功能研究
- 批准号:31100871
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
铁磁、半金属-超导异质结中电子输运的理论研究
- 批准号:60971053
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
CaMK II信号转导通路参与前扣带回皮质调节IBS大鼠的内脏痛觉
- 批准号:30800512
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
Riesz乘积和树上的分枝测度的重分形分析
- 批准号:10826054
- 批准年份:2008
- 资助金额:3.0 万元
- 项目类别:数学天元基金项目
Posphoinositide-dependent kinase-1在肿瘤细胞趋化运动和转移中的作用机制
- 批准号:30772529
- 批准年份:2007
- 资助金额:29.0 万元
- 项目类别:面上项目
相似海外基金
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
- 批准号:
10660882 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
开发针对胰腺癌的条件装甲 CAR 巨噬细胞疗法
- 批准号:
10710883 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Characterization of disulfide modified diabetogenic neoepitopes
二硫键修饰的糖尿病新表位的表征
- 批准号:
10720644 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Tolerance-Inducing mRNA Nanoparticles to Treat Type 1 Diabetes
诱导耐受的 mRNA 纳米颗粒治疗 1 型糖尿病
- 批准号:
10835326 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Kynurenine-dependent redox signaling at the interface between innate and adaptive immunity
先天免疫和适应性免疫之间界面的犬尿氨酸依赖性氧化还原信号传导
- 批准号:
10749210 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
减弱封装胰岛移植中间接同种免疫反应的策略
- 批准号:
10678425 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
- 批准号:
10600510 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Investigating a novel role of DRAK2 in T cell migration and synapse formation
研究 DRAK2 在 T 细胞迁移和突触形成中的新作用
- 批准号:
10680274 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Biophysical parameters of self-reactive TCR engagement in T1D
T1D 中自反应 TCR 参与的生物物理参数
- 批准号:
10681917 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别: